Prevalence of Psoriatic Arthritis Patients Achieving Minimal Disease Activity in Real-world Studies and Randomized Clinical Trials: Systematic Review with Metaanalysis.
Mariele Zardin-MoraesAndré Luis Ferreira Azeredo da SilvaCarla SaldanhaCharles Lubianca KohemLaura C CoatesLilian Rodrigues HenriquePenelope Esther PalominosRafael Mendonça da Silva ChakrPublished in: The Journal of rheumatology (2019)
Patients with PsA included in real-world studies had similar prevalence of MDA compared to those in controlled clinical trials. This finding suggests that MDA is a useful treatment target for PsA in the real-world setting.
Keyphrases
- disease activity
- systematic review
- prostate cancer
- clinical trial
- end stage renal disease
- rheumatoid arthritis
- systemic lupus erythematosus
- risk factors
- rheumatoid arthritis patients
- chronic kidney disease
- newly diagnosed
- breast cancer cells
- ankylosing spondylitis
- case control
- prognostic factors
- peritoneal dialysis
- radical prostatectomy
- juvenile idiopathic arthritis
- randomized controlled trial
- cell death
- cell proliferation
- cell cycle arrest
- phase iii